Danaher, Merck KGaA, and SARTORIUS AG are Dominating the Global Laboratory Filtration Market in the year 2018

Global laboratory filtration market is growing at a substantial CAGR of 7.7% in the forecast period of 2019 to 2026. The years considered for the study are as mentioned below.

Access Full Report at https://databridgemarketresearch.com/reports/global-laboratory-filtration-market

Global laboratory filtration market is a highly concentrated market which includes key players and local players. The market has witnessed various strategic developments owing to favourable market scenario. The market has a prominent growth in upcoming years due to increasing requirements of purified products in various industries and rising focus on developing large-molecule biopharmaceuticals. Development of new filtration products with advanced technology is also posing as an opportunity for the market.

The market has witness developments in terms of merger and acquisitions or product launches to enhance the product portfolio to meet the rising demand of innovative technology. In May 2015, Danaher announced that they have acquired Pall Corporation (U.S). Pall Corporation is a leading provider of filtration, separation and purification solutions that remove contaminants or separate substances from a variety of solids, liquids and gases. After this acquisition Pall Corporation provide leading business with significant runway for expansion and strengthens of Danaher life sciences position in the strategically-attractive, high-growth biopharmaceutical market.

Danaher dominated the global laboratory filtration market. The other key players existing in the market includes Merck KGaA, and Sartorius AG. The other key players in the market are ALFA LAVAL, AD INSTRUMENTS, GVS S.p.A, Thermo Fisher Scientific Inc., GENERAL ELECTRIC, 3M, MACHEREY-NAGEL GmbH & Co. KG, MEISSNER FILTRATION PRODUCTS, INC., DrM, Dr. Mueller AG, Cantel Medical , Repligen Corporation , Advanced Microdevices Pvt. Ltd. and among others.

Danaher

Danaher headquartered in Pennsylvania, U.S. was founded in 1969. The company is engaged in helping customers achieve high standards by innovating forward-looking technologies to solve customers’ most complex challenges. The company has four business segments that are life science, diagnostics, dental, environmental & applied solutions. Market focused segment is life science.

  • In May 2015, Danaher announced that they have acquired Pall Corporation (U.S). Pall Corporation is a leading provider of filtration, separation and purification solutions that remove contaminants or separate substances from a variety of solids, liquids and gases. After this acquisition Pall Corporation provide leading business with significant runway for expansion and strengthens of Danaher life sciences position in the strategically-attractive, high-growth biopharmaceutical market.

The company has its global presence in North America, Europe, Asia-Pacific, South America, Middle East and Africa. The company has various subsidiaries such as ALLTEC/FOBA (Germany), BeckmanCoulter (U.S.), Implant Direct (U.S.), KaVo Kerr (U.S.) and others.

Merck KGaA:

Merck KGaA, headquartered in Darmstadt, Germany was founded in 1668. The company focuses on the development and manufacturing of medicines and intelligent devices that provide ongoing care for patients beyond their treatment. The company has three business segments that are life science, healthcare, and performance material.

The company has global presence in North America, Asia-Pacific, Europe, South America, Middle East & Africa. The company has various subsidiaries such as Sigma-Aldrich (U.S.), Merck Millipore Limited (Ireland), Allergopharma GmbH & Co. KG (Germany), MERCK, S.L.U (Spain), Merck (Pvt) Ltd (Pakistan), Seven Seas Ltd (U.K.) and others.

Sartorius AG:

Sartorius AG, headquartered in Goettingen, Germany was founded in 1870. The company focuses on manufacturing devices for biomolecular and microbial separations, cell culture, concentration, fermentation, and purification. The company has two business segments that are bioprocess solutions, lab products & services. Market focused segment is lab products & services.

  • In May 2019, Sartorius Stedim Biotech launches new ambr 15 cell culture microbioreactor system. This product improved design of clone selection as well as media and feed optimization in fed-batch and perfusion mimic conditions. This new system supports Cell & Gene therapy applications, including HEK293 for viral vector production, T-cells, iPSCs and other immune-derived cell lines.

The company has global presence in North America, South America, Europe, Asia-Pacific, Middle East and Africa. The company has various subsidiaries such as Sartorius StedimBiotech (France), IntelliCyt Corporation (USA), Toha Plast GmbH (Germany), Sartorius BBI Systems GmbH (Germany), Vivascience AG (Germany) and others.